AVNT Q1 2026 Earnings EPS Edges Past Estimates Stock Gains 286 FBLG Q1 2026 Earnings PreRevenue Biotech Posts Slight EPS Miss No Revenue Reported FWRG Q1 2026 Earnings EPS Miss Weighs on Results Despite Positive Stock Reaction MGA Q1 2026 Earnings Strong EPS Beat of 33 Drives Positive Market Reaction PZZA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment NTRSO Preferred Shares Hold Steady Near 1870 as Support Levels Tested BristolMyers Squibb BMY Modestly Declines as Resistance Holds Hillman Solutions HLMN Gains 152 Approaches Key Resistance Level Establishment Labs ESTA Posts Modest Gain as Shares Hold Above Key Support Tenet Healthcare THC Q1 2026 Earnings Strong EPS Beat Masks Market Skepticism